Dimensional Fund Advisors
BNGO icon

Dimensional Fund Advisors’s Bionano Genomics BNGO Stock Holding History

Dimensional Fund Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-517
Closed -$21K – 3358
2024
Q2 		$21K Sell
517
-305
-37% -$16.8K ﹤0.01% 3349
2024
Q1 		$54.8K Sell
822
-767
-48% -$57.2K ﹤0.01% 3328
2023
Q4 		$180K Sell
1,589
-3,567
-69% -$373K ﹤0.01% 3208
2023
Q3 		$937K Buy
5,156
+5,130
+19,731% +$1.34M ﹤0.01% 2942
2023
Q2 		$9.37K Sell
26
-31
-54% -$14K ﹤0.01% 3474
2023
Q1 		$38.2K Sell
57
-112
-66% -$99.5K ﹤0.01% 3405
2022
Q4 		$148 Hold
169
– – ﹤0.01% 3277
2022
Q3 		$186K Buy
+169
New +$223K ﹤0.01% 3253

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

Dimensional Fund Advisors's BNGO Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Bionano Genomics (BNGO) in Q3 2024, closing a stake of 517 shares — an estimated $21K sold.

Dimensional Fund Advisors first reported a position in BNGO in Q3 2022 and held it in 8 quarters. The position peaked at $937K in Q3 2023. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Bionano Genomics position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 517 Bionano Genomics shares in Q3 2024, an estimated $21K.
  • Dimensional Fund Advisors first reported a position in Bionano Genomics in Q3 2022 and held it in 8 quarters.
  • Dimensional Fund Advisors's Bionano Genomics position peaked at $937K in Q3 2023.
  • 47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.